Leqvio Európska únia - slovenčina - EMA (European Medicines Agency)

leqvio

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - Činidlá modifikujúce lipidy - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

Atorvastatin Teva Pharma 10 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

atorvastatin teva pharma 10 mg

teva pharmaceuticals slovakia s.r.o., slovensko - atorvastatín - 31 - hypolipidaemica

Atorvastatin Teva Pharma 20 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

atorvastatin teva pharma 20 mg

teva pharmaceuticals slovakia s.r.o., slovensko - atorvastatín - 31 - hypolipidaemica

Atorvastatin Teva Pharma 40 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

atorvastatin teva pharma 40 mg

teva pharmaceuticals slovakia s.r.o., slovensko - atorvastatín - 31 - hypolipidaemica

Atorvastatin Teva Pharma 80 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

atorvastatin teva pharma 80 mg

teva pharmaceuticals slovakia s.r.o., slovensko - atorvastatín - 31 - hypolipidaemica